Methylation of SHOX2 or SEPT9 was detected in ascites samples of patients suffering from different malignancy entities including, among others, ovarian cancer, hepatic or pancreatic cancer, gallbladder or bile duct cancer, and non-Hodgkin lymphoma (Table 4, Additional file 1). This evidence concerns the gene SHOX2 and ovarian cancer.